Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Urologic neoplasms | D014571 | — | C64-C68 | — | 1 | — | — | — | 1 |
Carcinoma | D002277 | — | C80.0 | — | 1 | — | — | — | 1 |
Transitional cell carcinoma | D002295 | — | — | — | 1 | — | — | — | 1 |
Non-small-cell lung carcinoma | D002289 | — | — | 1 | 1 | — | — | — | 1 |
Lung neoplasms | D008175 | — | C34.90 | 1 | 1 | — | — | — | 1 |
Drug common name | VACTOSERTIB |
INN | vactosertib |
Description | Vactosertib is a small molecule pharmaceutical. It is currently being investigated in clinical studies. The pharmaceutical is active against activin receptor type-1B and TGF-beta receptor type-1. |
Classification | Small molecule |
Drug class | serine/threonine kinase inhibitors |
Image (chem structure or protein) | ![]() |
Structure (InChI/SMILES or Protein Sequence) | Cc1cccc(-c2[nH]c(CNc3ccccc3F)nc2-c2ccc3ncnn3c2)n1 |
PDB | — |
CAS-ID | 1352608-82-2 |
RxCUI | — |
ChEMBL ID | CHEMBL3260567 |
ChEBI ID | — |
PubChem CID | — |
DrugBank | — |
UNII ID | 6T4O391P5Y (ChemIDplus, GSRS) |